Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
31 Oct 2019
Historique:
received: 28 01 2019
revised: 14 06 2019
accepted: 03 10 2019
entrez: 2 11 2019
pubmed: 2 11 2019
medline: 28 5 2020
Statut: ppublish

Résumé

The immune microenvironment of hepatocellular carcinoma (HCC) is poorly characterized. Combining two single-cell RNA sequencing technologies, we produced transcriptomes of CD45

Identifiants

pubmed: 31675496
pii: S0092-8674(19)31119-5
doi: 10.1016/j.cell.2019.10.003
pii:
doi:

Substances chimiques

Cation Transport Proteins 0
GPNMB protein, human 0
LAMP3 protein, human 0
Lysosomal Membrane Proteins 0
Membrane Glycoproteins 0
Neoplasm Proteins 0
metal transporting protein 1 0
Leukocyte Common Antigens EC 3.1.3.48

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

829-845.e20

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Qiming Zhang (Q)

BIOPIC, Beijing Advanced Innovation Center for Genomics, School of Life Sciences, Peking University, Beijing 100871, China.

Yao He (Y)

Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China.

Nan Luo (N)

Department of Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China; Ninth School of Clinical Medicine, Peking University, Beijing 100038, China.

Shashank J Patel (SJ)

Department of Cancer Immunology and Immune Modulation, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT 06877, USA.

Yanjie Han (Y)

BIOPIC, Beijing Advanced Innovation Center for Genomics, School of Life Sciences, Peking University, Beijing 100871, China.

Ranran Gao (R)

BIOPIC, Beijing Advanced Innovation Center for Genomics, School of Life Sciences, Peking University, Beijing 100871, China.

Madhura Modak (M)

Department of Cancer Immunology and Immune Modulation, Boehringer Ingelheim Pharma, Birkendorfer Str. 65, 88400 Biberach, Germany.

Sebastian Carotta (S)

Department of Cancer Cell Signaling, Boehringer Ingelheim RCV GmBH & Co KG., Dr. Boehringer Gasse 5-11, 1120 Vienna, Austria.

Christian Haslinger (C)

Department of Computational Biology and Genomics, Boehringer Ingelheim Pharma, Birkendorfer Str. 65, 88400 Biberach, Germany.

David Kind (D)

Department of Computational Biology and Genomics, Boehringer Ingelheim Pharma, Birkendorfer Str. 65, 88400 Biberach, Germany.

Gregory W Peet (GW)

Department of Cancer Immunology and Immune Modulation, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT 06877, USA.

Guojie Zhong (G)

BIOPIC, Beijing Advanced Innovation Center for Genomics, School of Life Sciences, Peking University, Beijing 100871, China.

Shuangjia Lu (S)

BIOPIC, Beijing Advanced Innovation Center for Genomics, School of Life Sciences, Peking University, Beijing 100871, China.

Weihua Zhu (W)

Department of Hepatobiliary Surgery, Peking University People's Hospital, Beijing 100044, China.

Yilei Mao (Y)

Department of Liver Surgery, Peking Union Medical College Hospital, Beijing 100730, China.

Mengmeng Xiao (M)

Department of Retroperitoneal Tumor Surgery, Peking University International Hospital, Beijing 102206, China.

Michael Bergmann (M)

Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

Xueda Hu (X)

BIOPIC, Beijing Advanced Innovation Center for Genomics, School of Life Sciences, Peking University, Beijing 100871, China.

Sid P Kerkar (SP)

Department of Cancer Immunology and Immune Modulation, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT 06877, USA.

Anne B Vogt (AB)

Department of Human Cancer Immunology, Boehringer Ingelheim RCV GmBH & Co KG., Dr. Boehringer Gasse 5-11, 1120 Vienna, Austria.

Stefan Pflanz (S)

Department of Cancer Immunology and Immune Modulation, Boehringer Ingelheim Pharma, Birkendorfer Str. 65, 88400 Biberach, Germany.

Kang Liu (K)

Department of Cancer Immunology and Immune Modulation, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT 06877, USA. Electronic address: kang_3.liu@boehringer-ingelheim.com.

Jirun Peng (J)

Department of Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China; Ninth School of Clinical Medicine, Peking University, Beijing 100038, China. Electronic address: pengjr@medmail.com.cn.

Xianwen Ren (X)

BIOPIC, Beijing Advanced Innovation Center for Genomics, School of Life Sciences, Peking University, Beijing 100871, China. Electronic address: renxwise@pku.edu.cn.

Zemin Zhang (Z)

BIOPIC, Beijing Advanced Innovation Center for Genomics, School of Life Sciences, Peking University, Beijing 100871, China; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China. Electronic address: zemin@pku.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH